Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine

Intramuscular vaccines have greatly reduced hospitalization and death due to severe COVID-19. However, most countries are experiencing a resurgence of infection driven predominantly by the Delta and Omicron variants of SARS-CoV-2. In response, booster dosing of COVID-19 vaccines has been implemented...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Jiun, Lin, Meei-Yun, Chuang, Ya-Shan, Liu, Luke Tzu-Chi, Kuo, Tsun-Yung, Chen, Charles, Ganesan, Shyamala, Fattom, Ali, Bitko, Vira, Lien, Chia-En
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255510/
https://www.ncbi.nlm.nih.gov/pubmed/35790783
http://dx.doi.org/10.1038/s41598-022-15238-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255510/
https://www.ncbi.nlm.nih.gov/pubmed/35790783
http://dx.doi.org/10.1038/s41598-022-15238-y

Ejemplares similares